Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Fuji
Chubb
Chinese Patent Office
McKesson
Moodys
Cantor Fitzgerald
Dow
Healthtrust

Generated: August 19, 2018

DrugPatentWatch Database Preview

DEXAMETHASONE SODIUM PHOSPHATE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dexamethasone Sodium Phosphate, and what generic alternatives are available?

Dexamethasone Sodium Phosphate is a drug marketed by Akorn, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Fresenius Kabi Usa, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Somerset Theraps Llc, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Sola Barnes Hind, Bausch And Lomb, and Sandoz Inc. and is included in thirty-one NDAs.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

Drug patent expirations by year for DEXAMETHASONE SODIUM PHOSPHATE
Pharmacology for DEXAMETHASONE SODIUM PHOSPHATE
Synonyms for DEXAMETHASONE SODIUM PHOSPHATE
(11|A,16|A)-9-Fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)pregna-1,4-diene-3,20-dione
(11alpha,16alpha)-9-Fluoro-11,17-Dihydroxy-16-Methyl-3,20-Dioxopregna-1,4-Dien-21-Yl Dihydrogen Phosphate
(11beta,16alpha)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl dihydrogen phosphate
(11beta,16alpha)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate
[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate
{2-[(1R,2S,10S,11S,13R,14R,15S,17S)-1-FLUORO-14,17-DIHYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHOXY}PHOSPHONIC ACID
1869-92-7
21-Disodium phosphate dexamethasone
2392-39-4
2BP70L44PR
312-93-6
392D394
3T5
3tc5
54302-EP2305219A1
54302-EP2308562A2
54302-EP2371811A2
55203-24-2
65184-38-5
9-Fluoro-11|A,17,21-trihydroxy-16|A-methylpregna-1,4-diene-3,20-dione 21-Phosphate
9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate)
9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate) disodium salt
A816989
A830522
AB1009274
AC-17992
AC1L1SYG
AC1L291E
AC1NTURW
AC1Q1UXS
AI9376Y64P
AJ-46482
AK-51738
Ak-Dex
AK103580
AKOS015896357
AKOS015951212
AKOS016007098
AM84812
AN-14018
AN-40448
AN-50017
AX8235119
Baldex
BC213122
BDBM235670
Betnelan phosphate
C08175
C22H28FNa2O8P
C22H28FO8P.2Na
CAS-2392-39-4
CHEBI:4462
CHEBI:68637
CHEBI:68638
CHEMBL1200637
CHEMBL1201302
CHEMBL2021430
Colvasone
CS-0013899
D00975
D07802
D0NA8U
Dalalone
Dalalone (TN)
Decadron Inhalation, Injection, Ophthalmic Solution and Ointment, and Topical Cream
Decadron phosphate
Decadron-phosphate (TN)
Decdan
Dex 21-P (red blood cell encapsulated), Urbino University/EryDel
Dexabene
Dexadreson
Dexagel
Dexagro
Dexaject SP
Dexamethason sodium phosphate
Dexamethasone 21-(dihydrogen phosphate)
Dexamethasone 21-(disodium phosphate)
Dexamethasone 21-(sodium hydrogen phosphate)
Dexamethasone 21-Dihydrogen Phosphate
Dexamethasone 21-orthophosphate
Dexamethasone 21-phosphate
Dexamethasone 21-phosphate disodium salt
Dexamethasone 21-phosphate disodium salt, >=98%
Dexamethasone disodium phosphate
Dexamethasone Orthophosphate
dexamethasone phosphate
Dexamethasone phosphate disodium
dexamethasone phosphate(2-)
DEXAMETHASONE PHOSPHORIC ACID
Dexamethasone sodium phosphate (erythrocyte encapsulated)
Dexamethasone sodium phosphate (erythrocyte encapsulated), Urbino University/EryDel
Dexamethasone sodium phosphate (JAN/USP)
Dexamethasone Sodium Phosphate [USAN:BAN:JAN]
Dexamethasone sodium phosphate [USP:BAN:JAN]
Dexamethasone sodium phosphate for peak identification, European Pharmacopoeia (EP) Reference Standard
Dexamethasone sodium phosphate, European Pharmacopoeia (EP) Reference Standard
Dexamethasone Sodium Phosphate, pharmaceutical secondary standard; traceable to USP, PhEur, BP
Dexamethasone sodium phosphate, United States Pharmacopeia (USP) Reference Standard
Dexamethasone-21-dihydrogen-phosphate
Dexamethasone-21-phosphate
Dexamethasone-21-phosphate disodium salt
dexamethasone;
Dexamethasone21-phosphatedisodiumsalt
DEXAMETHASONESODIUMPHOSPHATE
Dexamethazone sodium phosphate
disodium (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-14-[2-(phosphonatooxy)acetyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
disodium (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-14-[2-(phosphonatooxy)acetyl]tetracyclo[8.7.0.0?,?.0??,??]heptadeca-3,6-dien-5-one
disodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] phosphate
disodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
disodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
disodium 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate
Disodium dexamethasone phosphate
disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
DSSTox_CID_27429
DSSTox_GSID_47429
DSSTox_RID_82342
DTXSID2047430
DTXSID3047429
EBD26577
EINECS 206-232-0
EINECS 217-487-2
EINECS 219-243-0
EN300-52795
erydex
FT-0603099
FT-0659571
FT-0666306
Hexadrol Injectable
Hexadrol phosphate
HMS2231O20
HY-B1829A
I06-1906
Intra-erythrocyte dexamethasone (inflammatory diseases), Urbino University/EryDel
J10230
KB-271918
KB-296233
KS-1150
LS-118469
LS-118471
LS-187216
Maxidex Ointment
Megacort
MFCD00079105
Micromethason
MLS000069568
MLS000863280
MLS001076081
MolPort-002-529-303
MolPort-005-937-094
MQRFYYBWKRACSJ-WKSAPEMMSA-M
NCGC00021226-03
NCGC00021226-04
NCGC00094644-01
NCGC00256783-01
Neodecadron
Onadron
Opera_ID_74
Oradexon phosphate
Orgadrone
Phosphoric acid hydrogen (9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl)=sodium ester salt
PL009466
PLCQGRYPOISRTQ-FCJDYXGNSA-L
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-(dihydrogen phosphate)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-(dihydrogen phosphate) disodium salt
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy- 16-methyl-21-(phosphonooxy)-, (11ss,16?)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11beta,16alpha)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, sodium salt (1:2), (11beta,16alpha)-
Q-200940
s4028
SC-18764
SCHEMBL135283
SCHEMBL3694078
SCHEMBL7778
SMR000058813
sodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] hydrogen phosphate
sodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
Sodium dexamethasone phosphate
Soldesam
Solu-Decadron
Spersadox
STOCK1N-57166
TL8001979
Tox21_113181
Tox21_302586
UNII-2BP70L44PR
UNII-AI9376Y64P
VQODGRNSFPNSQE-CXSFZGCWSA-N
Wymesone
ZINC3876071

US Patents and Regulatory Information for DEXAMETHASONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OPHTHALMIC, OTIC 088771-001 Jan 16, 1985 AT RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OTIC 084855-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Akorn DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate INJECTABLE;INJECTION 084493-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate INJECTABLE;INJECTION 084355-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate INJECTABLE;INJECTION 085641-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate INJECTABLE;INJECTION 040572-001 Apr 22, 2005 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Colorcon
Chinese Patent Office
Citi
Medtronic
US Army
Fuji
AstraZeneca
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.